Cytokines, Signaling and Diseases - A Pharmacologist's View

Drug News and Perspectives

Volumn 17, Issue 1, 2004, Pages 67-80

  Doggrell, Sheila A ^a  

^a Doggrell Biomedical Communications   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

1 O (ALPHA GALACTOPYRANOSYL) 2 HEXACOSANOYLAMINO 1,3,4 OCTADECANETRIOL; 4 [N [1 (2 CYANO 1 OXOETHYL) 4 METHYL 3 PIPERIDINYL] N METHYLAMINO]PYRROLO[2,3 D]PYRIMIDINE; ANTINEOPLASTIC AGENT; CBL PROTEIN; CYC 11158; CYC 11647; CYC 11675; CYC 11679; CYC 11977; CYTOKINE; DACLIZUMAB; IMATINIB; INTERFERON; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 31; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN KINASE INHIBITOR; RETINOID INTERFERON INDUCED MORTALITY 19; STAT PROTEIN; TYRPHOSTIN B42; UNCLASSIFIED DRUG;

ASTHMA; CANCER; CANCER CHEMOTHERAPY; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIABETES MELLITUS; DRUG RESEARCH; DRUG TARGETING; HUMAN; IMMUNE RESPONSE; IMMUNITY; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SOLID TUMOR;

ABORTION, SPONTANEOUS; ANIMALS; ASTHMA; CENTRAL NERVOUS SYSTEM DISEASES; CYTOKINES; DIABETES MELLITUS; IMMUNITY, NATURAL; MYOCARDITIS; NEOPLASMS; STEM CELL TRANSPLANTATION;

EID: 1842476904     PISSN: 02140934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (47)

1. Berg, T., Cohen, S.B., Desharnais, J. et al. Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts. Proc Nat Acad Sci USA 2002, 99: 3830-5.
2. Ulane, C.M. and Horvath, C.M. Paramyxo-viruses SV5 and HPIV2 assemble STAT protein ubiquitin ligase complexes from cellular components. Virology 2002, 304: 160-6.
3. Durbin, J.E., Hackenmiller, R., Simon, M.C. and Levy, D.E. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 1996, 84: 443-50.
4. Pilz, A., Ramsauer, K., Heidari, H., Leitges, M., Kovarik, P. and Decke, T. Phosphorylation of the Stat1 transactivating domain is required for the response to type I interferons. EMBO Rep 2002, 4: 368-73.
5. Stockinger, S., Materna, T., Stoiber, D. et al. Production of type I IFN sensitizes macrophages to cell death induced by Listeria monocytogenes. J Immunol 2002, 169: 6522-9.
6. Karanghiosoff, M., Steinborn, R., Kovarik, P. et al. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nat Immunol 2003, 4: 471-4.
7. Fitzgerald, K.A., Palsson-McDermott, E.M., Bowie, A.G. et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-signal transduction. Nature 2001, 413: 78-83.
8. Fitzgerald, K.A., Rowe, D.C., Barnes, B.J. et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the adopters TRAM and TRIF. J Exp Med 2003, 198: 1043-55.
9. Sharma, S., tenOever, B.R., Grandvaux, N., Zhou, G.P., Lin, R. and Hiscott, J. Triggering the interferon antiviral response through an IKK-related pathway. Science 2003, 300: 1148-50.
10. Stojdl, D.L., Lichty, B.D., tenOever, B.R. et al. VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents. Cancer Cell 2003, 4: 263-75.
11. Nguyen, K.B., Watford, W.T., Salomon, R. et al. Critical role for STAT4 activation by type I interferons in the interferon-gamma response to viral infection. Science 2002, 297: 2063-6.
12. Croker, B.A., Krebs, D.L., Zhang, J.G. et al. SOCS3 negatively regulated IL-6 signaling in vivo. Nat Immunol 2003, 4: 540-5.
13. Cornish, A.L., Chong, M.M., Davey, G.M. et al. Suppressor of cytokine signaling-1 regulates signaling in response to interleukin-2 and other gamma c-dependent cytokines in peripheral T cells. J Biol Chem 2003, 278: 22755-61.
14. Yasukawa, H., Ohishi, M., Mori, H. et al. IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages. Nat Immunol 2003, 4: 551-6.
15. Soubeyran, P., Kowanetz, K., Szymkiewicz, K., Langdon, W.Y. and Dikic, I. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 2002, 416: 183-7.
16. Cui, Z., Willingham, M.C., Hicks, A.M. et al. Spontaneous regression of advanced cancer: Identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci USA 2003, 100: 6682-7.
17. Zhang, J., Yang, J., Roy, S.K. et al. The cell death regulator GRIM-19 is an inhibitor of signal transducer and activator of transcription 3. Proc Natl Acad Sci USA 2003, 100: 9642-7.
18. Barnes, B.J., Kellum, M.J., Pinder, K.E., Frisancho, J.A. and Pitha, P.M. Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res 2003, 63: 6424-31.
19. Shankaran, V., Ikeda, H., Bruce, A.T. et al. IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity. Nature 2001, 410: 1107-11.
20. Street, S.E., Trapani, J.A., MacGregor, D. and Smyth, M.J. Suppression of lymphoma and epithelial malignancies effected by interferon gamma. J Exp Med 2002, 196: 129-34.
21. Takeda, K., Smyth, M.J., Cretney, E. et al. Critical role for tumor necrosis factor apoptosis-inducing ligand in immune surveillance against tumor development. J Exp Med 2002, 195: 161-6.
22. Hayakawa, Y., Rovero, S., Forni, G. and Smyth, M.J. Alpha-galactosylceramide (KRN7000) suppression of chemical and oncogene-dependent carcinogenesis. Proc Natl Acad Sci USA 2003, 100: 9464-9.
23. Giaccone, G., Punt, C.J., Ando, Y. et al. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Clin Cancer Res 2002, 8: 3702-9.
24. Mattes, J., Hulett, M., Xie, W. et al. Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process. J Exp Med 2003, 197: 387-93.
25. Carr, D.J., Al-khatib, K., James, C.M. and Silverman, R. Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. J Neuroimmunol 2003, 141: 40-6.
26. Wang, J., Schreiber, R.D. and Campbell, I.L. STAT1 deficiency unexpectedly and markedly exacerbates the pathophysiological actions of IFN-alpha in the central nervous system. Proc Natl Acad Sci USA 2002, 99: 16209-14.
27. Wang, J., Pham-Mitchell, N., Schindler, C. and Campbell, I.L. Dysregulated Sonic hedgehog signaling and medulloblastoma consequent to IFN-alpha-stimulated STAT2-independent production of IFN-gamma in the brain. J Clin Invest 2003, 112: 535-43.
28. Crack, P.J., Taylor, J.M., Flentjar, N.J. et al. Increased infarct size and exacerbated apoptosis in the glutathione peroxidase-1 (Gpx-1) knockout mouse brain in response to ischemia/reperfusion injury. J Neurochem 2001, 78: 1389-99.
29. Serra, C., Mameli, G., Arru, G. et al. In vitro modulation of the multiple sclerosis (MS)-associated retrovirus by cytokines: Implications for MS pathogenesis. J Neurovirol 2003, 9: 637-43.
30. McQualter, J.L., Darwiche, R., Ewing, C. et al. Granulocyte macrophage colony-stimulating factor: A new putative therapeutic target in multiple sclerosis. J Exp Med 2001, 194: 873-82.
31. Lenzo, J.C., Mansfield, J.P., Sivamoorthy, S., Cull, V.S. and James, C.M. Cytokine expression in murine cytomegalovirus-induced myocarditis: Modulation with interferon-alpha therapy. Cell Immunol 2003, 223: 77-86.
32. Kuhl, U., Pauschinger, M., Schwimmbeck, P.L. et al. Interferon-beta treatment eliminates cardiotrophic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 2003, 107: 2793-8.
33. Groom, J., Kalled, S.L., Cutler, A.H. et al. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome. J Clin Invest 2002, 109: 59-68.
34. Gronthos, S., Zannettino, A.C., Hay, S.J. et al. Malecular and cellular characterization of highly purified stromal cells derived from human bone marrow. J Cell Sci 2003, 116: 1827-35.
35. Magavi, S.S., Leavitt, B.R. and Macklis, J.D. Induction of neurogenesis in the neocortex of adult mice. Nature 2000, 405: 951-5.
36. Rietze, R.L., Valcanis, H., Brooker, G.F., Thomas, T., Voss, A.K. and Bartlett, P.F. Purification of a pluripotent neural stem cell from the adult mouse brain. Nature 2001, 412: 736-9.
37. Turnley, A.M., Faux, C.H., Rietze, R.L., Coonan, J.R. and Bartlett, P.F. Suppressor of cytokine signaling 2 regulates neuronal differentiation by inhibiting growth hormone signaling. Nat Neurosci 2002, 5: 1155-62.
38. Alonso, L. and Fuchs, E. Stem cells of the skin epithelium. Proc Natl Acad Sci 2003, 100(Suppl 1): 11830-5.
39. Yoshikawa, H., Matsubara, K., Qian, G.S. et al. SOC-I, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 2001, 28: 29-35.
40. Wilks, A.F. Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. Proc Natl Acad Sci USA 1989, 86: 1603-7.
41. Carswell, C.I., Plosker, G.L. and Wagstaff, A.L. Daclizumab: A review of its use in the management of organ transplantation. BioDrugs 2001, 15: 745-73.
42. Changelian, P.S., Flanagan, M.E., Ball, D.J. et al. Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science 2003, 302: 875-8.
43. Lynch, D.H. and Yang, X.D. Therapeutic potential of ABX-EGF: A fully human anti-epidermal growth factor receptor monoclonal antibody for cancer treatment. Semin Oncol 2002, 29(Suppl 4): 47-50.
44. Meropol, N.J., Somer, R.A., Gutheil, J. et al. Randomised phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: Potential role as mucosal protectant. J Clin Oncol 2003, 21: 1452-8.
45. Nutt, J.G., Burchiel, K.J., Comella, C.L. et al. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 2003, 60: 69-73.
46. Gill, S.S., Patel, N.K., Hotton, G.R. et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003, 9: 589-95.
47. Mould, A.W., Tonks, I.D. et al. Vegfb gene knockout mice display reduced pathology and synovial angiogenesis in both antigen-induced and collagen-induced models of arthritis. Arthritis Rheum 2003, 48: 2660-9.